Navigation Links
Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries)
Date:12/8/2009

panish Market for Drug-Eluting-Stents, 2005 - 2015(Euro) . 166

Figure 6-59 Spanish Market for Drug-Eluting Stents, 2005 - 2015(US$) ......... 166

Figure 6-60 Leading Competitors, Spanish Market for Drug-Eluting Stents, 2008167

Figure 6-61 Beneluxian Market for Coronary Stents, Units per PCI Procedure,

2005 - 2015 ....... 168

Figure 6-62 Belgian Market for Coronary Stents, Units per PCI Procedure, 2005 -

2015 ...... 170

Figure 6-63 Dutch Market for Coronary Stents, Units per PCI Procedure, 2005 -

2015 ...... 170

Figure 6-64 Beneluxian Market for Coronary Stents by Type, 2005 - 2015(Euro) ... 171

Figure 6-65 Beneluxian Market for Coronary Stents by Type, 2005 - 2015(US$)171

Figure 6-66 Beneluxian Market for Bare-Metal Stents, 2005 - 2015(Euro)............ 173

Figure 6-67 Beneluxian Market for Bare-Metal Stents, 2005 - 2015(US$) ......... 173

Figure 6-68 Belgian Market for Bare-Metal Stents, 2005 - 2015(Euro) .... 174

Figure 6-69 Belgian Market for Bare-Metal Stents, 2005 - 2015(US$) ............ 174

Figure 6-70 Dutch Market for Bare-Metal Stents, 2005 - 2015(Euro) ...... 175

Figure 6-71 Dutch Market for Bare-Metal Stents, 2005 - 2015(US$) 175

Figure 6-72 Leading Competitors, Beneluxian Market for Bare-Metal Stents,

2008 ...... 176

Figure 6-73 Beneluxian Market for Drug-Eluting-Stents, 2005 - 2015(Euro) .......... 178

Figure 6-74 Beneluxian Market for Drug-Eluting Stents, 2005 - 2015(US$) ...... 178

Figure 6-75 Belgian Market for Drug-Eluting-Stents, 2005 - 2015(Euro) . 179

Figure 6-76 Belgian Market for Drug-Eluting Stents, 2005 - 2015(US$) ......... 179

Figure 6-77 Dutch Market for Drug-Eluting-Stents, 2005 - 2015(Euro) ... 180

Figure 6-78 Dutch Market for Drug-Eluting Stents, 2005 - 2015(US$) ............ 1
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
2. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
3. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
4. Reportlinker Adds Antiseptics and Disinfectants Report
5. Reportlinker Adds Commercial Amino Acids Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
8. Reportlinker Adds Pediatric Health Care Products and Services Report
9. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
10. Reportlinker Adds 2008/2009 Healthcare Research Review Report
11. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... New York, NY (PRWEB) , ... July 01, 2015 , ... ... around which DNA is wound, histones, remain constant in the brain, never changing after ... Sinai have discovered that histones are steadily replaced in brain cells throughout life – ...
(Date:7/1/2015)... PA (PRWEB) , ... July 01, 2015 , ... ... purist natural forms, such as organically raised chickens and eggs. Eating organic foods ... backyard chickens is cleaner and more environmentally friendly than production chicken farming. Choosing ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... enterprise of Hospital Corporation of America (HCA), as it further expands its Strategic ... today. , With this new partnership, OncLive’s editorial and marketing teams will ...
(Date:7/1/2015)... ... , ... Lisa Keys, the widow of U.S. Army Master Sergeant Bradley Keys, ... memory of her late husband and all of America’s fallen military and first responders. ... died during a Special Forces training exercise in December of 2012. The ‘Legacy 5K’ ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... Transformation Task Force, contributing to newly released white paper: “Pro-actively Identifying the High-Cost ... was published July 1st and is available at: http://www.hcttf.org/resouces-tools . , The ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3
... (Nasdaq: GTIV ), the nation,s leading provider of,comprehensive ... is,scheduled to present from 1:30 p.m. to 2:00 p.m. ... Healthcare Conference in San Francisco., The event will ... web cast,which may be accessed by visiting http://investors.gentiva.com/events.cfm ...
... toys get kids moving, researchers say , WEDNESDAY, Dec. 26 ... toys can boost just how much exercise youngsters get at ... epidemic that threatens the future health of our nation. We ... in the United States attend child-care centers, so it,s important ...
... MED ) announced today that it has been ... it is not in compliance with the NYSE,s,continued listing ... because over a consecutive 30-day trading period its total ... most recently,reported shareholders, equity was below $75 million. Under ...
... LAKE FOREST, Ill., Dec. 26 Hospira, Inc.,(NYSE: ... today,that Christopher B. Begley, chairman and chief executive officer, ... Healthcare Conference on,Wednesday, Jan. 9, 2008, at the Westin ... is scheduled to begin at 9:30 a.m. Pacific Time ...
... Reactions are less predictable, more aggressive than 20 years ago, ... milk and egg allergies may be more persistent and harder ... report. , In two studies from the Johns Hopkins Children,s ... and almost 900 youngsters with egg allergy for more than ...
... PALO ALTO, Calif., Dec. 26 Varian Medical,Systems, ... has completed the acquisition,of Pan-Pacific Enterprises, Inc., the ... for the purpose of marketing, sales, and,distribution of ... acquiring,the privately held business for approximately $2 million ...
Cached Medicine News:Health News:Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco 2Health News:Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco 3Health News:Study Spotlights 'Exercise-Friendly' Day-Care Centers 2Health News:Medifast Receives Notice Regarding NYSE Listing 2Health News:Medifast Receives Notice Regarding NYSE Listing 3Health News:Medifast Receives Notice Regarding NYSE Listing 4Health News:Medifast Receives Notice Regarding NYSE Listing 5Health News:Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9 2Health News:Fewer Children Outgrowing Allergies to Milk, Eggs 2Health News:Varian Medical Systems Acquires Pan-Pacific Enterprises for Marketing, Sales and Distribution of X-Ray Imaging Products in China 2Health News:Varian Medical Systems Acquires Pan-Pacific Enterprises for Marketing, Sales and Distribution of X-Ray Imaging Products in China 3
(Date:7/1/2015)... Ill. , July 1, 2015 ... nationwide group of state and regional professional rheumatology ... survey of rheumatologists that explored perceptions of biosimilars ... on patients. Biosimilars are medicines ... biologic medicines. They are notably different from generic ...
(Date:7/1/2015)... 1, 2015 Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... corporate presentation at the Cantor Fitzgerald Healthcare Conference in ... Russell Cox , executive vice president and chief ... a business and financial update on Wednesday, July 8, 2015 ... A live audio webcast of the presentation may be ...
(Date:7/1/2015)... , July 1, 2015 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... Fitzgerald Inaugural Healthcare Conference taking place in ... at Le Parker Meridien Hotel. ... overview of the Company,s business during his live presentation ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 2ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2
... 3 Glufosfamide and Phase 2 Glufosfamide Plus ... Gemcitabine Clinical Trials to be Presented, REDWOOD CITY, Calif., ... announced two presentations,regarding its oncology product candidate glufosfamide. The presentations,will ... held,September 23 to 27, 2007, at the International Conference Center ...
... First Hsp90 Inhibitor to Enter Registration Trials, HAYWARD, ... ) today announced that it has successfully,reached a binding ... the design of its TIME-1 clinical trial, a pivotal ... treatment for patients with,multiple myeloma. Through the FDA,s Special ...
Cached Medicine Technology:Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 2Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 2Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 4Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 5Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 6Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 7
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: